PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 19 filers reported holding PLX PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 245 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -99.1% | 245 | -99.1% | 0.00% | – |
| Q1 2022 | $116,000 | -37.3% | 28,702 | +24.2% | 0.00% | – |
| Q4 2021 | $185,000 | -31.7% | 23,107 | +64.4% | 0.00% | – |
| Q3 2021 | $271,000 | +135.7% | 14,057 | +69.3% | 0.00% | – |
| Q2 2021 | $115,000 | – | 8,305 | +16510.0% | 0.00% | – |
| Q1 2021 | $0 | – | 50 | +4900.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | -98.6% | 0.00% | – |
| Q2 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 73 | +265.0% | 0.00% | – |
| Q4 2019 | $0 | – | 20 | -63.0% | 0.00% | – |
| Q3 2019 | $0 | – | 54 | +5300.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $403,000 | 0.96% |
| Park West Asset Management LLC | 1,075,723 | $6,918,000 | 0.41% |
| 683 Capital Management, LLC | 249,300 | $1,603,000 | 0.17% |
| Heritage Way Advisors, LLC | 28,000 | $180,000 | 0.15% |
| Harel Insurance Investments & Financial Services Ltd. | 250,000 | $145,000 | 0.01% |
| UBS Group AG | 11,840 | $76,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,302 | $8,000 | 0.00% |
| FAYEZ SAROFIM & CO | 13,729 | $89,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2 | $0 | 0.00% |